These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21575805)

  • 41. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
    Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
    Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants--but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis.
    Huusom LD; Secher NJ; Pryds O; Whitfield K; Gluud C; Brok J
    BJOG; 2011 Jan; 118(1):1-5. PubMed ID: 21197681
    [No Abstract]   [Full Text] [Related]  

  • 43. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years.
    Schendel DE; Berg CJ; Yeargin-Allsopp M; Boyle CA; Decoufle P
    JAMA; 1996 Dec; 276(22):1805-10. PubMed ID: 8946900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fetal pharmacotherapy 3: magnesium sulfate.
    Namouz-Haddad S; Koren G
    J Obstet Gynaecol Can; 2013 Dec; 35(12):1101-1104. PubMed ID: 24405877
    [No Abstract]   [Full Text] [Related]  

  • 45. Magnesium sulfate and risk of cerebral palsy in very low-birth-weight infants.
    Nelson KB
    JAMA; 1996 Dec; 276(22):1843-4. PubMed ID: 8946908
    [No Abstract]   [Full Text] [Related]  

  • 46. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia.
    Grether JK; Hoogstrate J; Walsh-Greene E; Nelson KB
    Am J Obstet Gynecol; 2000 Sep; 183(3):717-25. PubMed ID: 10992199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. More on prenatal magnesium sulfate and risk of cerebral palsy.
    Nelson KB; Grether JK
    JAMA; 1997 Nov; 278(18):1493. PubMed ID: 9363965
    [No Abstract]   [Full Text] [Related]  

  • 48. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
    Nelson KB; Grether JK
    Pediatrics; 1995 Feb; 95(2):263-9. PubMed ID: 7838646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
    Wolf HT; Huusom LD; Henriksen TB; Hegaard HK; Brok J; Pinborg A
    BJOG; 2020 Sep; 127(10):1180-1188. PubMed ID: 32237069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral Palsy in Very Preterm Infants: A Nine-Year Prospective Study in a French Population-Based Tertiary Center.
    Chollat C; Bertrand E; Petit-Ledo A; de Vansay C; Voisin C; Dabaj I; Gillibert A; Marret S;
    J Pediatr; 2021 Oct; 237():183-189.e6. PubMed ID: 34144033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
    Ow LL; Kennedy A; McCarthy EA; Walker SP
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of magnesium sulfate in obstetrics].
    Kayem G; Mandelbrot L; Haddad B
    Gynecol Obstet Fertil; 2012 Oct; 40(10):605-13. PubMed ID: 22995056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hope for perinatal prevention of cerebral palsy.
    Tyson JE; Gilstrap LC
    JAMA; 2003 Nov; 290(20):2730-2. PubMed ID: 14645316
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of antenatal magnesium sulfate treatment for neonatal neuro-protection on cerebral oxygen kinetics.
    Stark MJ; Hodyl NA; Andersen CC
    Pediatr Res; 2015 Sep; 78(3):310-4. PubMed ID: 25985294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.
    Horton AL; Lai Y; Rouse DJ; Spong CY; Leveno KJ; Varner MW; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; O'Sullivan MJ; Hankins GD; Caritis SN;
    Am J Perinatol; 2015 Mar; 32(4):387-92. PubMed ID: 25241107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnesium sulfate for fetal neuroprotection.
    Rouse DJ
    Am J Obstet Gynecol; 2011 Oct; 205(4):296-7. PubMed ID: 22083052
    [No Abstract]   [Full Text] [Related]  

  • 57. What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ; Hirtz D;
    Semin Perinatol; 2016 Aug; 40(5):303-6. PubMed ID: 27117179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand.
    Bain E; Goodchild L; Lontis R; McIntyre S; Ashwood P; Bubner T; Middleton P; Crowther C
    Aust Nurs J; 2013 Jul; 21(1):34-7. PubMed ID: 23930314
    [No Abstract]   [Full Text] [Related]  

  • 59. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ; Hirtz DG; Thom E; Varner MW; Spong CY; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Alexander JM; Harper M; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; Moawad A; O'Sullivan MJ; Peaceman AM; Hankins GD; Langer O; Caritis SN; Roberts JM;
    N Engl J Med; 2008 Aug; 359(9):895-905. PubMed ID: 18753646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conclusive meta-analyses on antenatal magnesium may be inconclusive! Are we underestimating the risk of random error?
    Brok J; Huusom LD; Thorlund K
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1247-51. PubMed ID: 23016676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.